Sabbin Ci gaban Clinical don Maganin Ciwon Jijiyoyin Jiji

A KYAUTA Kyauta 1 | eTurboNews | eTN
Avatar na Linda Hohnholz
Written by Linda Hohnholz

AffaMed Therapeutics, wani kamfani na kimiyyar halittu na duniya a matakin asibiti wanda aka sadaukar don haɓakawa da kasuwancin samfuran magunguna, dijital da na tiyata, a yau ya sanar da cewa Hukumar Abinci da Magunguna ta Amurka (FDA) ta share aikace-aikacenta na Sabon Magunguna (IND) don haɓaka asibiti. AM712 (ASKG712), wani labari mai mallakar bispecific biolocule biolocule wanda ke toshe nau'ikan haɓakar haɓakar jijiyoyi biyu (VEGF) da angiopoietin-2 (Ang-2) don maganin cututtukan jijiyoyin bugun jini.

A ƙarƙashin wannan IND, nan ba da jimawa ba AffaMed zai fara nazarin Mataki na 1 a cikin Amurka don bincika aminci, juriya, magunguna, da ingancin AM712 a cikin batutuwa tare da AMD neovascular.

AffaMed Therapeutics kwanan nan ya shiga yarjejeniya ta lasisi tare da AskGene Pharma Inc. don keɓantaccen haƙƙoƙin haɓakawa, ƙira da tallata AM712 a tsohuwar Asiya da yankunan Japan a duniya.

"Muna farin cikin yin haɗin gwiwa tare da AskGene kuma mun karɓi izinin IND na farko daga FDA." Dr. Dayao Zhao, babban jami'in AffaMed ya yi tsokaci cewa: "A matsayin wani bangare na dabarun kirkire-kirkire na kasar Sin ga duniya don yin amfani da karfin kasancewar AffaMed a kasar Sin da Amurka don ciyar da fannoni daban-daban na kiwon lafiya a kasuwannin duniya, wannan yarjejeniya ta lasisi tana kara karfafa bututun likitan ido na duniya. . Na yi matukar farin cikin shaida saurin aiwatar da wannan dabarar daga ba da lasisi zuwa izinin IND na Amurka kuma ina fatan samun haɗin gwiwa tare da AskGene. "

"AskGene ya himmatu wajen kawo lafiya da inganci magunguna ga marasa lafiya ta hanyar amfani da sabbin fasahohi. Mun yi matukar farin cikin ba da haɗin kai tare da AffaMed don haɓaka ƙwararrun ƙwayoyin cuta na anti-VEGF/ANG2 bispecific AMG712(ASKG712) don amfanar marasa lafiya" in ji Babban Jami'in AskGene Dokta Jeff Lu: "Kwararrun ƙwarewar duniya ta ƙungiyar AffaMed a yankin ido. mahimmancin la'akari don haɗin gwiwarmu. Yin aiki tare, za mu iya haɓaka ci gaban ASKG712 a duniya. "

Dokta Ji Li, Shugaban AffaMed yayi sharhi: "Mun yi imanin AM712 yana da yuwuwar zama mafi kyawun ajin anti-VEGF/Ang-2 bispecific kwayoyin halitta don magance manyan buƙatun likita waɗanda ba a cika su ba tsakanin marasa lafiya da cututtukan jijiyoyin jini. Mun yi farin cikin nuna ƙarfin aiwatar da mu don karɓar izinin IND na Amurka a cikin watanni 2 bayan kammala yarjejeniyar lasisi tare da AskGene. "

Game da marubucin

Avatar na Linda Hohnholz

Linda Hohnholz

Edita a shugaba don eTurboNews bisa ga eTN HQ.

Labarai
Sanarwa na
bako
0 comments
Bayanin Cikin Lissafi
Duba duk maganganu
0
Za a son tunanin ku, don Allah sharhi.x
()
x
Share zuwa...